CRC pathogenesis is driven by Wnt hyperactivation primarily due to active nuclear β-catenin due to APC loss or CTNNB1 activating mutations, a state that is analogous to persistent Wnt-on phase. This evidence concerns the gene CTNNB1 and colorectal carcinoma.